Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
40 studies found for:    " September 19, 2012":" October 19, 2012"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Show Display Options
RSS Create an RSS feed from your search for:
" September 19, 2012":" October 19, 2012"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Need help? See RSS Feeds
Choose a feed type:
Show studies first received on any dateShow studies that were first received in the last 14 days
Show studies last updated date on any dateShow studies that were added or modified in the last 14 days
Rank Status Study
1 Completed Safety and Immunogenicity Study of SeV-G(NP) HIV Vaccine Administered Intranasally and Ad35-GRIN HIV Vaccine Given Intramuscularly in Prime-Boost Regimens in HIV-Uninfected Volunteers
Condition: HIV Infections
Interventions: Biological: SeV-G(NP) (0.2mL, 2x10^7 CIU);   Biological: SeV-G(NP) (0.2mL, 2x10^8 CIU);   Biological: Ad35-GRIN (0.5mL)
2 Completed First Study to Evaluate the Capacity of Maraviroc Drug to Protect Against HIV Infection in Samples of Rectal Mucosa From Healthy Volunteers
Condition: HIV
Interventions: Drug: Maraviroc;   Drug: TVD 300/200 QD
3 Completed Immune Reconstitution in HIV Disease (IREHIV)
Condition: HIV Infection
Interventions: Drug: vitamin D (cholecalciferol) and PBA (sodium phenylbutyrate);   Drug: Placebo tablets
4 Completed Evaluation of Safety and Efficacy of the PrePexTM Device for Rapid Scale up of Adult MC Programs in Zimbabwe
Conditions: Circumcision Adult;   HIV CDC Category B2;   HIV Infections
Intervention: Device: PrePex™ device
5 Active, not recruiting Treatment of Acute HIV Infection With Quad Fixed-dose Combination (FDC) Tablet
Condition: HIV
Intervention: Drug: (FDC) ELV/COBI/FTC/TDF
6 Active, not recruiting
Has Results
Safety and Efficacy of E/C/F/TDF (Stribild®) Versus RTV-Boosted ATV Plus FTC/TDF (Truvada®) in HIV-1 Infected, Antiretroviral Treatment-Naive Women
Conditions: Acquired Immunodeficiency Syndrome;   HIV Infections
Interventions: Drug: E/C/F/TDF;   Drug: RTV;   Drug: ATV;   Drug: FTC/TDF;   Drug: E/C/F/TDF Placebo;   Drug: RTV Placebo;   Drug: ATV Placebo;   Drug: FTC/TDF Placebo;   Drug: E/C/F/TAF
7 Recruiting Evaluating a Structural and Behavioral HIV Risk Reduction Program for Black Men
Condition: HIV
Interventions: Behavioral: MEN Count;   Behavioral: Comparison
8 Completed Comparing the PrePex™ Device to Surgical MC for Rapid Scale Up of MC in Resource Limited Setting
Condition: HIV
Interventions: Device: PrePex™ device for adult male circumcision;   Procedure: Surgical circumcision
9 Completed Safety and Immunogenicity of ChAdV63.HIVconsv and MVA.HIVconsv Candidate HIV-1 Vaccines in Recently HIV-1 Infected Individuals
Condition: HIV
Interventions: Biological: 0-24 week prime/boost regimen;   Biological: 0-8 week prime/boost regimen
10 Completed HOPE (Harnessing Online Peer Education): Using Online Social Networks for HIV Prevention and Testing
Condition: HIV
Intervention: Behavioral: HIV knowledge Intervention
11 Recruiting SANKOFA Pediatric HIV Disclosure Intervention
Condition: HIV
Interventions: Behavioral: Disclosure intervention;   Behavioral: Enhanced usual care
12 Completed CARE Corrections: Technology for Jail HIV/HCV Testing, Linkage, and Care (TLC)
Condition: Human Immunodeficiency Virus
Interventions: Device: Intervention Arm (computer-based CARE+ Corrections tool);   Other: Educational video on opiate overdose prevention
13 Completed Observational Study of Male Circumcision Using PrePex Device
Condition: HIV
Intervention: Device: PrePex device for male circumcision
14 Recruiting Comparison of Two IUDs Among Cape Town HIV-positive Women
Condition: HIV
Interventions: Device: Mirena levonorgestrel IUD;   Device: Copper T-380a IUD
15 Completed HIV Prevention for Injecting Drug Users in Kazakhstan
Conditions: HIV;   AIDS
Interventions: Behavioral: Couples Based HIV/STI Risk Reduction Intervention (CHSR);   Behavioral: Renaissance Wellness Promotion (WP)
16 Unknown  A Pilot Study on Raltegravir, Tenofovir and Emtricitabine for Peri-exposure Prophylaxis for HIV Infection
Conditions: Infection;   HIV
Intervention: Drug: Truvada and Isentress
17 Unknown  A Pilot Study to Assess the Feasibility of Switching, Individuals Receiving Atripla With Continuing Central Nervous System (CNS) Toxicity, to a Fixed Dose Combination of Tenofovir/Emtricitabine/Rilpivirine
Condition: HIV
Intervention: Drug: tenofovir/emtricitabine/rilpivirine
18 Recruiting Management of Highly Active Anti-retroviral Therapy-related Hyperlipidemia Among HIV-infected Patients in Taiwan
Condition: HIV
Intervention:
19 Active, not recruiting A Clinical Trial Comparing the Efficacy of Tenofovir Disoproxil Fumarate/Emtricitabine/Rilpivirine (TDF/FTC/RPV) Versus TDF/FTC/Efavirenz (TDF/FTC/EFV) in Patients With Undetectable Plasma HIV-1 RNA on Current First-line Treatment
Condition: Human Immunodeficiency Virus-type 1 Infection
Interventions: Drug: Rilpivirine;   Drug: Efavirenz;   Drug: Tenofovir disoproxil fumarate;   Drug: Emtricitabine
20 Active, not recruiting Network Supported Engagement In HIV Care
Conditions: HIV;   Patient Acceptance of Health Care
Intervention: Other: Supportive Care

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.